Insider · CIK 0001602727

Firuta Paul E

Reports to the SEC for 3 companies · BEDMINSTER, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001602727

Forms 4 and 5

Insider transactions

17 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-01-28	ACHILLION PHARMACEUTICALS INCStock Options (Right to buy)D Disposition to Issuer	EVP, Chief Commercial Officer	DDisposition to Issuer	−400K sh	—	—	0
2020-01-28	ACHILLION PHARMACEUTICALS INCStock Options (Right to buy)D Disposition to Issuer	EVP, Chief Commercial Officer	DDisposition to Issuer	−200K sh	—	—	0
2019-01-23	ACHILLION PHARMACEUTICALS INCStock Option (Right to buy)A Award	EVP, Chief Commercial Officer	AAward	+200K sh	—	—	200,000
2018-09-11	ACHILLION PHARMACEUTICALS INCEmployee Stock OptionA Award	EVP, Chief Commercial Officer	AAward	+400K sh	—	—	400,000
2018-01-26	QUREuniQure N.V.A Award	Chief Commercial Officer	AAward	+8,566 sh	—	—	93,817
2018-01-26	QUREuniQure N.V. · Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+22.8K sh	—	—	22,843
2018-01-03	QUREuniQure N.V.S Sale	Chief Commercial Officer	SSale	−5,864 sh	$20.13	−$118K	85,251
2017-12-13	QUREuniQure N.V.A Award	Chief Commercial Officer	AAward	+56.1K sh	—	—	56,115
2017-01-27	QUREuniQure N.V. · Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+43.3K sh	—	—	43,250
2017-01-27	QUREuniQure N.V. · Preformance Share UnitA Award	Chief Commercial Officer	AAward	+43.3K sh	—	—	43,250
2017-01-27	QUREuniQure N.V. · Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+43K sh	—	—	43,000
2017-01-27	QUREuniQure N.V. · Preformance Share UnitA Award	Chief Commercial Officer	AAward	+43.5K sh	—	—	43,500
2015-02-21	NPS PHARMACEUTICALS INCU Disposition from Tender	President, US Comm Operations	UDisposition from Tender	−1,114 sh	$46.00	−$51.2K	0
2015-02-21	NPS PHARMACEUTICALS INCStock Options (right to buy)D Disposition to Issuer	President, US Comm Operations	DDisposition to Issuer	−58.4K sh	—	—	0
2015-02-21	NPS PHARMACEUTICALS INCRestricted Stock UnitsD Disposition to Issuer	President, US Comm Operations	DDisposition to Issuer	−10.9K sh	—	—	0
2015-02-21	NPS PHARMACEUTICALS INCRestricted Stock UnitsD Disposition to Issuer	President, US Comm Operations	DDisposition to Issuer	−21.4K sh	—	—	0
2015-02-12	NPS PHARMACEUTICALS INCRestricted Stock UnitsA Award	President, US Comm Operations	AAward	+10.9K sh	—	—	10,905

Recent filings

Accepted (ET)
Jan 294
Firuta Paul E0001562180-20-000669
SEC(opens sec.gov)
Jan 254
Firuta Paul E0001209191-19-005365
SEC(opens sec.gov)
Sep 124
Firuta Paul E0001209191-18-050688
SEC(opens sec.gov)
Jan 304
Firuta Paul E0000904454-18-000070
SEC(opens sec.gov)
Jan 34
Firuta Paul E0001209191-18-001200
SEC(opens sec.gov)
Dec 154
Firuta Paul E0001209191-17-065946
SEC(opens sec.gov)
Feb 214/A
uniQure N.V.0001140361-17-008376
SEC(opens sec.gov)
Jan 314
uniQure N.V.0001140361-17-003717
SEC(opens sec.gov)
Feb 244
NPS PHARMACEUTICALS INC0001104659-15-013591
SEC(opens sec.gov)
Feb 204
NPS PHARMACEUTICALS INC0001104659-15-012639
SEC(opens sec.gov)

Companies

Address

550 HILLS DRIVE

BEDMINSTER, NJ, 07921